Expand KURA Menu
KURA MENU

KURA Latest Press Releases

-- May 26, 2026 --

Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors Globe Newswire 6:02 AM

-- May 19, 2026 --

Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit Globe Newswire 4:02 PM

-- May 12, 2026 --

Kura Oncology Reports First Quarter 2026 Financial Results Globe Newswire 4:02 PM
Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress Globe Newswire 9:40 AM

-- May 6, 2026 --

Kura Oncology to Participate in Bank of America Securities Healthcare Conference Globe Newswire 7:30 AM

-- May 5, 2026 --

Kura Oncology to Report First Quarter 2026 Financial Results Globe Newswire 7:30 AM

-- May 4, 2026 --

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- April 24, 2026 --

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML Globe Newswire 8:00 AM

-- April 17, 2026 --

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib Globe Newswire 6:00 AM

-- April 9, 2026 --

Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026 Globe Newswire 7:30 AM

-- April 3, 2026 --

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- March 6, 2026 --

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- March 5, 2026 --

Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 6:31 AM

-- February 26, 2026 --

Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 7:30 AM

-- February 25, 2026 --

Kura Oncology to Participate in Three Upcoming Investor Conferences Globe Newswire 7:30 AM

-- February 6, 2026 --

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- January 11, 2026 --

Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones Globe Newswire 5:00 PM

-- January 5, 2026 --

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM
Market Data Delayed 15 Minutes